Literature DB >> 8564230

Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.

Y Kitagawa1, S Adachi-Akahane, T Nagao.   

Abstract

1. The relative proportions of beta 1- and beta 2-adrenoceptors were determined by radioligand binding studies in three different rat myocardial preparations: membranes prepared from rat ventricle (ventricular membranes), membranes prepared from rat isolated ventricular myocytes (myocyte membranes), and myocytes isolated from rat ventricle (myocytes). 2. Competition experiments using CGP 20712A or ICI 118,551 with [125I]-iodocyanopindolol ([125I]-ICYP) revealed high- and low-affinity binding sites in ventricular membranes. The concentration at which each beta-antagonist occupied 100% of its high-affinity binding sites was 300 nM for CGP 20712A (beta 1-adrenoceptor) and 50 nM for ICI 118,551 (beta 2-adrenoceptor). 3. The density of high-affinity (beta 1-adrenoceptor) and low-affinity (beta 2-adrenoceptor) binding sites for CGP 20712A was measured by a saturation experiment using [125I]-ICYP in the presence and absence of 300 nM CGP 20712A. In ventricular membranes, the proportions of high-affinity and low-affinity binding sites for CGP 20712A were 73% and 27%, respectively, whereas in myocyte membranes, the corresponding figures were 90% and 10%, respectively. The density of low-affinity binding sites for CGP 20712A in ventricular membranes, defined as [125I]-ICYP-specific binding in the presence of 300 nM CGP 20712A, was decreased by addition of 50 nM ICI 118,551, whereas that in myocyte membranes was not affected. 4. In myocytes, specific binding of [125I]-ICYP and [3H]-CGP 12177 was not detected by saturation experiments performed in the presence of 300 nM CGP 20712A. 5 In myocytes, the activation of adenylate cyclase caused by beta2-adrenoceptors was not detected in the presence of 10 nM, 100 nM or 1000 nM CGP 20712A, which selectively antagonized beta1-adrenoceptors.Furthermore, the concentration-response curve for isoprenaline-stimulated cyclic AMP accumulation was not shifted by 10 nm or 100 nM ICI 118,551, which selectively antagonized beta2-adrenoceptors, but was shifted to the right by 1000 nM ICI 118,551.6 These results indicate that beta2-adrenoceptors are not present on rat ventricular myocytes and that beta2-adrenoceptor stimulation does not cause any detectable production of cyclic AMP. We conclude that only beta1-adrenoceptors exist on rat ventricular myocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564230      PMCID: PMC1908905          DOI: 10.1111/j.1476-5381.1995.tb16384.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

Authors:  M Honma; T Satoh; J Takezawa; M Ui
Journal:  Biochem Med       Date:  1977-12

3.  The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations.

Authors:  Y Yabuuchi
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

4.  Dissociation constants and relative efficacies of agonists acting on alpha adrenergic receptors in rabbit aorta.

Authors:  J C Besse; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

5.  Molecular cloning and expression of the rat beta 3-adrenergic receptor.

Authors:  J G Granneman; K N Lahners; A Chaudhry
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

6.  Beta 1-adrenoceptor stimulation and beta 2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells.

Authors:  R P Xiao; E G Lakatta
Journal:  Circ Res       Date:  1993-08       Impact factor: 17.367

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Beta-adrenoceptor-binding studies of the cardioselective beta blockers bisoprolol, H-I 42 BS, and HX-CH 44 BS to heart membranes and intact ventricular myocytes of adult rats: two beta 1-binding sites for bisoprolol.

Authors:  A B Mauz; H Pelzer
Journal:  J Cardiovasc Pharmacol       Date:  1990-03       Impact factor: 3.105

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.

Authors:  N Blin; L Camoin; B Maigret; A D Strosberg
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

View more
  5 in total

1.  Role of β-adrenergic receptor regulation of TNF-α and insulin signaling in retinal Muller cells.

Authors:  Robert J Walker; Nancy M Anderson; Youde Jiang; Suleiman Bahouth; Jena J Steinle
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-16       Impact factor: 4.799

2.  Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium.

Authors:  D R Varma; H Shen; X F Deng; K G Peri; S Chemtob; S Mulay
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Cytoskeletal role in protection of the failing heart by β-adrenergic blockade.

Authors:  Guangmao Cheng; Harinath Kasiganesan; Catalin F Baicu; J Grace Wallenborn; Dhandapani Kuppuswamy; George Cooper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

4.  Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.

Authors:  Torsten Christ; Alejandro Galindo-Tovar; Marcus Thoms; Ursula Ravens; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

5.  Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.

Authors:  Sarah M Schumacher; Erhe Gao; Weizhong Zhu; Xiongwen Chen; J Kurt Chuprun; Arthur M Feldman; John J G Tesmer; Walter J Koch
Journal:  Sci Transl Med       Date:  2015-03-04       Impact factor: 17.956

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.